Cardlytics(CDLX)
Search documents
Cardlytics (CDLX) Under Investor Scrutiny About Growth Initiatives – Hagens Berman
GlobeNewswire News Room· 2024-08-13 22:34
SAN FRANCISCO, Aug. 13, 2024 (GLOBE NEWSWIRE) -- Hagens Berman urges Cardlytics, Inc. (NASDAQ: CDLX) investors who suffered substantial losses to submit your losses now. The firm also encourages persons with knowledge who may be able to assist in the investigation to contact its attorneys. Visit: www.hbsslaw.com/investor-fraud/cdlx Contact the Firm Now: CDLX@hbsslaw.com 844-916-0895 Investigation Into Cardlytics, Inc. (CDLX): Cardlytics Inc. is facing scrutiny from prominent shareholder rights firm Hagens B ...
SHAREHOLDER ALERT: Investigation Into Cardlytics, Inc. (CDLX) Announced byHolzer & Holzer, LLC
GlobeNewswire News Room· 2024-08-12 14:26
ATLANTA, Aug. 12, 2024 (GLOBE NEWSWIRE) -- Holzer & Holzer, LLC is investigating whether Cardlytics, Inc. ("Cardlytics" or the "Company") (NASDAQ: CDLX) complied with federal securities laws. On August 7, 2024, Cardlytics reported financial results for its second quarter ended June 30, 2024, including a decrease of 9% year-over-year in revenue, stating "our results were challenged by slower-than-anticipated billings growth coupled with higher consumer incentives." Following this news, the price of the Compa ...
CARDLYTICS ALERT: Bragar Eagel & Squire, P.C. is Investigating Cardlytics, Inc. on Behalf of Cardlytics Stockholders and Encourages Investors to Contact the Firm
GlobeNewswire News Room· 2024-08-11 01:00
NEW YORK, Aug. 10, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Cardlytics, Inc. ("Cardlytics" or the "Company") (NASDAQ:CDLX) on behalf of Cardlytics stockholders. Our investigation concerns whether Cardlytics has violated the federal securities laws and/or engaged in other unlawful business practices. Click here to participate in the action. On August 7, 2024, Cardlytics announced its second quarter 202 ...
Johnson Fistel Begins Investigation into Cardlytics Following a Significant Drop in the Company's Stock
GlobeNewswire News Room· 2024-08-08 13:43
SAN DIEGO, Aug. 08, 2024 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP is investigating whether Cardlytics, Inc. (NASDAQ: CDLX) or any of its executive officers or others violated securities laws by misrepresenting or failing to timely disclose material, adverse information to investors. The investigation focuses on investors' losses and whether they may be recovered under federal securities laws. What if I purchased Cardlytics securities? If you purchased securities and suffered losse ...
Cardlytics(CDLX) - 2024 Q2 - Earnings Call Transcript
2024-08-08 00:24
Cardlytics, Inc. (NASDAQ:CDLX) Q2 2024 Earnings Conference Call August 7, 2024 5:00 PM ET Company Participants Nick Lynton - Chief, Legal & Privacy Officer Jack Klinck - Chairperson of the Board Amit Gupta - Chief Operating Officer Alexis DeSieno - Chief Financial Officer Conference Call Participants Jaeson Schmidt - Lake Street Capital Markets Kyle Peterson - Needham Luke Horton - Northland Capital Markets Jason Kreyer - Craig-Hallum Operator Good day, and thank you for standing by. Welcome to the Cardlyti ...
Cardlytics(CDLX) - 2024 Q2 - Quarterly Report
2024-08-07 20:30
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _________________ to _________________ Commission File Number: 001-38386 CARDLYTICS, INC. (Exact Name of Registrant as Specified in its Charter) Delaware ...
Cardlytics(CDLX) - 2024 Q2 - Quarterly Results
2024-08-07 20:16
Exhibit 99.1 Cardlytics Announces Second Quarter 2024 Financial Results Atlanta, GA – August 7, 2024 – Cardlytics, Inc. (NASDAQ: CDLX), a digital advertising platform, today announced financial results for the second quarter ended June 30, 2024. "We continue to believe in the significant growth opportunity as we invest to modernize our platform. We are making progress, but transitions like this take time and these near-term challenges do not change the long-term potential of this business," said Amit Gupta, ...
Cardlytics Announces Timing of Its Second Quarter 2024 Earnings Release
GlobeNewswire News Room· 2024-07-24 20:05
About Cardlytics Contacts: ATLANTA, July 24, 2024 (GLOBE NEWSWIRE) -- Cardlytics, Inc. (NASDAQ: CDLX), an advertising platform in banks' digital channels, today announced that its second quarter ended June 30, 2024 financial results will be released on August 7, 2024, after market close. The results will be discussed via conference call at 5:00 PM (ET) / 2:00 PM (PT). Investor Relations: ir@cardlytics.com The company invites investors to join a live audio webcast at http://ir.cardlytics.com/ or to dial-in b ...
Why Cardlytics Stock Collapsed on Thursday
The Motley Fool· 2024-05-09 18:38
Cardlytics' Q1 loss may have been bigger than you realize.Shares of advertising technology company Cardlytics (CDLX -34.31%) imploded Thursday morning, falling 32% through 10:15 a.m. ET after reporting what -- in all honesty -- didn't look like much of a miss last night.Expected to report quarterly sales of $71.7 million in Q1, Cardlytics said it booked only $67.6 million in sales. However, Cardlytics actually beat average earnings estimates, losing only $0.09 per share where Wall Street had forecast an $0. ...
Why Is Cardlytics (CDLX) Stock Down 29% Today?
InvestorPlace· 2024-05-09 12:43
Cardlytics (NASDAQ:CDLX) stock is falling on Thursday after the advertising platform operator released its earnings report for the first quarter of 2024.That earnings report starts with revenue of $67.61 million for the quarter. This fails to reach Wall Street’s estimate of $71.69 million in revenue. However, it’s a 5.1% increase year-over-year from $64.33 million.Next, we have the company’s adjusted EPS of -9 cents. That’s better than the -11 cents per share that analysts were expecting. Even so, it’s an i ...